Patents by Inventor Liqin Yu

Liqin Yu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Amorphous solid dispersion comprising 6-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)nicotinamide
    Patent number: 12178808
    Abstract: The present invention relates to an amorphous solid dispersion comprises 6-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)nicotinamide (Compound I) or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable polymer. The present invention also relates to pharmaceutical compositions comprising the amorphous solid dispersion. The amorphous solid dispersion of the present invention is stable upon storage and provides a better dissolution rate and bioavailability when comparing with a crystalline form.
    Type: Grant
    Filed: April 27, 2021
    Date of Patent: December 31, 2024
    Assignee: Beijing InnoCare Pharma Tech Co., Ltd.
    Inventors: Xiangyang Chen, Zuopeng Wang, Liqin Yu
  • Crystalline forms of 6-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)nicotinamide
    Patent number: 11945792
    Abstract: The present invention relates to various crystalline forms of 6-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)nicotinamide. The present invention also relates to pharmaceutical compositions comprising the crystalline forms.
    Type: Grant
    Filed: March 3, 2021
    Date of Patent: April 2, 2024
    Assignee: Beijing Innocare Pharma Tech Co., Ltd
    Inventors: Xiangyang Chen, Zuopeng Wang, Liqin Yu
  • AMORPHOUS SOLID DISPERSION COMPRISING 6-(1-ACRYLOYLPIPERIDIN-4-YL)-2-(4-PHENOXYPHENYL)NICOTINAMIDE
    Publication number: 20210260050
    Abstract: The present invention relates to an amorphous solid dispersion comprises 6-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)nicotinamide (Compound I) or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable polymer. The present invention also relates to pharmaceutical compositions comprising the amorphous solid dispersion. The amorphous solid dispersion of the present invention is stable upon storage and provides a better dissolution rate and bioavailability when comparing with a crystalline form.
    Type: Application
    Filed: April 27, 2021
    Publication date: August 26, 2021
    Inventors: Xiangyang Chen, Zuopeng WANG, Liqin YU
  • CRYSTALLINE FORMS OF 6-(1-ACRYLOYLPIPERIDIN-4-YL)-2-(4-PHENOXYPHENYL)NICOTINAMIDE
    Publication number: 20210188801
    Abstract: The present invention relates to various crystalline forms of 6-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)nicotinamide. The present invention also relates to pharmaceutical compositions comprising the crystalline forms.
    Type: Application
    Filed: March 3, 2021
    Publication date: June 24, 2021
    Inventors: Xiangyang Chen, Zuopeng Wang, Liqin Yu